SCHEMBL1017833

SCHEMBL1017833

COc1cc(C)c(S(=O)(=O)CNCCc2nc3ccc(C(=O)O)cc3[nH]2)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.49
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 2/20 0.48
NPSR1 Q6W5P4 1/20 0.46
F9 P00740 2/20 0.45
THRB P10828 1/20 0.45
CHEK2 O96017 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
HSP90AA1 P07900 1/20 0.43
ESR2 Q92731 1/20 0.43
PTPN1 P18031 1/20 0.43
TOP2A P11388 1/20 0.41
MAPT P10636 4/20 0.41
TP53 P04637 2/20 0.41
DGAT1 O75907 1/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
F10 P00742 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL938644 0.91 NPSR1 (0.47) APEX1MAPK1ALDH1A1NPSR1F9
SCHEMBL11888799 0.81 KDM4C (0.38) MAPK1ALDH1A1THRBMAPTTP53
SCHEMBL1017834 0.80 APEX1 (0.50) APEX1MAPK1ALDH1A1NPSR1F9
SCHEMBL938645 0.80 NPSR1 (0.50) APEX1MAPK1ALDH1A1NPSR1CHEK2
SCHEMBL11888808 0.76 KDM4C (0.37) MAPK1ALDH1A1THRBMAPTTP53
SCHEMBL11888794 0.74 MAPT (0.45) APEX1MAPK1ALDH1A1F9THRB
SCHEMBL939162 0.73 ALDH1A1 (0.46) MAPK1ALDH1A1F9CHEK2MAPT
SCHEMBL941268 0.73 NPSR1 (0.47) APEX1MAPK1ALDH1A1NPSR1CHEK2
SCHEMBL6474118 0.72 APEX1 (0.74) APEX1MAPK1ALDH1A1NPSR1CHEK2
SCHEMBL29737966 0.72 APEX1 (0.69) APEX1MAPK1ALDH1A1NPSR1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 APEX1 3873/4885MAPK1 570/4885ALDH1A1 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.